Institut Curie-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Institut Curie - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014094
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biology and developmental biology, genetics and carcinogenesis, cell and tissue imaging, and others. It provides care, research and training services for detecting, treating and monitoring cancer. Institut Curie offers services in anesthesia, medicine, pediatrics, surgery, tumor biology, intensive care, pain, medical imaging, and others. The foundation provides masters, PhD and postdoctoral fellowship programmes and other courses. Institut Curie is headquartered in Paris, France.

Institut Curie – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institut Curie, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Curie, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Curie, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Curie, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Curie, Medical Devices Deals, 2011 to YTD 2017 9
Institut Curie, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Institut Curie, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Institut Curie Enters into Agreement with Pierre Fabre 11
Celyad Enters into Partnership with Institut Curie 12
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 13
Curie-Cancer Partners with Inventiva 14
Institut Curie Extends Research Agreement With Servier To Develop Breast Cancer Treatments 15
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 16
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 17
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 18
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 19
Licensing Agreements 20
Theravectys Enters into Licensing Agreement with Institut Curie 20
Abbott Molecular Enters into Licensing Agreement with Institut Curie 21
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 22
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 23
Institut Curie – Key Competitors 24
Institut Curie – Key Employees 25
Institut Curie – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Government and Public Interest 27
May 13, 2016: Cervical Cancer And The HPV Virus: A New Tool For Understanding Tumour Diversity 27
May 13, 2016: HIV: Entry Keys Discovered in the Cell Nucleus 28
May 13, 2016: Breast Cancer: Blocking The First Steps in Tumour Invasion 29
May 13, 2016: Cervical Cancer: Initial Results from a European Study 30
Product News 31
Oct 17, 2016: Leukaemia: discovery of an interrupter that causes the death of tumorous cells 31
Jun 24, 2016: Uveal Melanoma: A Promising Avenue for Treating Metastatic Forms 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Institut Curie, Pharmaceuticals & Healthcare, Key Facts 2
Institut Curie, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Curie, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Curie, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Curie, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Curie, Medical Devices Deals, 2011 to YTD 2017 9
Institut Curie, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Institut Curie Enters into Agreement with Pierre Fabre 11
Celyad Enters into Partnership with Institut Curie 12
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 13
Curie-Cancer Partners with Inventiva 14
Institut Curie Extends Research Agreement With Servier To Develop Breast Cancer Treatments 15
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 16
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 17
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 18
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 19
Theravectys Enters into Licensing Agreement with Institut Curie 20
Abbott Molecular Enters into Licensing Agreement with Institut Curie 21
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 22
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 23
Institut Curie, Key Competitors 24
Institut Curie, Key Employees 25

★海外企業調査レポート[Institut Curie-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Zayo Group LLC (ZAYO):企業の財務・戦略的SWOT分析
    Zayo Group LLC (ZAYO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kohler Co:企業の戦略的SWOT分析
    Kohler Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • DeepOcean Group Holding BV:企業の戦略的SWOT分析
    DeepOcean Group Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mayne Pharma Group Ltd (MYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Aeroport Anapa:企業の戦略・SWOT・財務分析
    Aeroport Anapa - Strategy, SWOT and Corporate Finance Report Summary Aeroport Anapa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Medikit Co Ltd (7749):企業の財務・戦略的SWOT分析
    Summary Medikit Co Ltd (Medikit) is a medical equipment provider that offers vascular devices. The company offers IV catheter, hemodialysis and intervention products. Its products include supercath Z3V, supercath 5 safety IV catheter, supercath AZ, supercath CLS, i-works, seiha, parent plus, parent …
  • Lukoil Oil Co (LKOH):企業の財務・戦略的SWOT分析
    Lukoil Oil Co (LKOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Merit Medical Systems Inc (MMSI):企業の財務・戦略的SWOT分析
    Merit Medical Systems Inc (MMSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ornim Inc-医療機器分野:企業M&A・提携分析
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development, and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow that is used …
  • Al Jaber Group:企業の戦略・SWOT・財務分析
    Al Jaber Group - Strategy, SWOT and Corporate Finance Report Summary Al Jaber Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mitsubishi Tanabe Pharma Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Tanabe Pharma Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Tanabe Pharma Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務分析
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Indivior Plc (INDV):企業の財務・戦略的SWOT分析
    Indivior Plc (INDV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lepanto Consolidated Mining Company:企業の戦略・SWOT・財務情報
    Lepanto Consolidated Mining Company - Strategy, SWOT and Corporate Finance Report Summary Lepanto Consolidated Mining Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    EnCana Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary EnCana Corp (EnCana) is an oil and gas producer. The company explores, develops, produces and markets natural gas, oil and natural gas liquids (NGLs). Its major resource plays include Montney, Duvernay, …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …
  • Clinuvel Pharmaceuticals Ltd (CUV):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinuvel Pharmaceuticals Ltd (Clinuvel Pharmaceuticals) is a biopharmaceutical company which focuses on the development of drugs for the treatment of severe skin disorders. Its lead product candidate, Scenesse (afamelanotide) is a first-in-class drug targeting erythropoietic protoporphyria ( …
  • CD Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CD Diagnostics Inc (CD Diagnostics), a subsidiary of Zimmer Biomet Holdings Inc, is a diagnostics company that develops immunoassays to improve patient outcomes. The company provides synovascure analytical tools. Its products are used in alpha defenses, CRP, hemoglobin tests, incubation of a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆